See every side of every news story

Browser Extension

Sunday, February 23, 2025

US Edition

Subscribe Login

Volodymyr Zelenskyy

Israel-Hamas Conflict

Innate-pharma.com image

News from Innate-pharma.com

News Home Page Local News Blindspot Feed International Covid-19

International North America South America Europe Asia Australia Africa

Trending Internationally Pope Francis Vatican Ukraine War Volodymyr Zelenskyy Olaf Scholz

Trending in U.S.Israel-Hamas Conflict Donald Trump US Politics Elon Musk Basketball

Trending in U.K.Israel-Hamas Conflict Manchester City Premier League Manchester United UK Politics

Trending Topics

Pope Francis Vatican Ukraine War Volodymyr Zelenskyy Israel-Hamas Conflict

CompanyAbout History Mission Blog Testimonials Group Subscriptions Subscribe Gift Free Trial Careers Affiliates

HelpHelp Center FAQ Contact Us For Educators/Libraries Media Bias Ratings Ownership and Factuality Ratings Referral Code News Sources Topics

ToolsApp Browser Extension Daily Newsletter Blindspot Report Newsletter Burst Your Bubble Newsletter Timelines

Donate Privacy Policy Manage Cookies Terms and Conditions

© 2025 Snapwise Inc

Blindspot Local

News from Innate-pharma.com

All of today’s top news stories from Innate-pharma.com. Get the full analysis behind how media bias impacts breaking news.

We’ve aggregated 2 of Innate-pharma.com’s headlines and news stories over the past 3 months.

We’ve assigned a media bias rating of to Innate-pharma.com. You can read more about our methodology here.

We’ve assigned a rating of Unknown factuality to Innate-pharma.com. You can read more about how we’ve determined Innate-pharma.com’s credibility and reliability as a news source here: https://groundnews.lakegeneva.lib.wi.us/rating-system.

All of today’s top news stories from Innate-pharma.com. Get the full analysis behind how media bias impacts breaking news. We’ve aggregated 2 of Innate-pharma.com’s headlines and news stories over the past 3 months.

We’ve assigned a media bias rating of to Innate-pharma.com. You can read more about our methodology here. We’ve assigned a rating of Unknown factuality to Innate-pharma.com. You can read more about how we’ve determined Innate-pharma.com’s credibility and reliability as a news source here: https://groundnews.lakegeneva.lib.wi.us/rating-system.

Information about Innate-pharma.com

Where is Innate-pharma.com located?Innate-pharma.com's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Innate-pharma.com News

Innate’s lacutamab gains FDA breakthrough therapy designation

United States · United States

Innate’s lacutamab gains FDA breakthrough therapy designation

Innate Pharma has gained breakthrough therapy designation for lacutamab to treat adults with relapsed or refractory Sézary syndrome.See the Story

You've scrolled to the bottom of the feed, there are no more stories.